Physician profile
Peter M Crane
NPI 1891960233
$1,802.26
in general payments reported to CMS, 2019-2025
23 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $136 · 2021: $300 · 2022: $377 · 2023: $144 · 2024: $247 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.25 | 2021-2025 | Qulipta |
| Novartis Pharmaceuticals Corporation | $188.30 | 2023-2025 | |
| Novo Nordisk INC | $165.05 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.94 | 2019-2021 | |
| Lilly USA, LLC | $94.92 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $93.00 | 2021-2024 | Farxiga |
| Arbor Pharmaceuticals, INC. | $68.03 | 2019 | |
| Amgen INC. | $63.20 | 2020-2023 | Evenity, Prolia |
| Allergan, INC. | $61.60 | 2019-2020 | |
| Pfizer INC. | $58.59 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $47.56 | 2019-2022 | |
| Abbott Laboratories | $41.18 | 2021-2022 | |
| Astellas Pharma US INC | $39.11 | 2019-2023 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.23 | 2019-2022 | |
| Seqirus USA INC | $26.37 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $25.96 | 2025 | Qelbree |
| Glaxosmithkline, LLC. | $22.71 | 2019-2020 | |
| Organon LLC | $22.09 | 2025 | Jada System |
| Exact Sciences Corporation | $21.22 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $20.36 | 2022 | |
| Dexcom, INC. | $16.84 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $14.72 | 2025 | |
| Medtronic, INC. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.